Eukles Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-268
Closed -$4.72K 227
2024
Q4
$4.72K Sell
268
-20
-7% -$371 ﹤0.01% 179
2024
Q3
$5.51K Sell
288
-35
-11% -$674 ﹤0.01% 175
2024
Q2
$7.05K Sell
323
-39
-11% -$1.04K ﹤0.01% 164
2024
Q1
$13.9K Sell
362
-782
-68% -$37.9K 0.01% 143
2023
Q4
$76.9K Sell
1,144
-77
-6% -$5.36K 0.04% 103
2023
Q3
$91.4K Hold
1,221
0.05% 101
2023
Q2
$113K Hold
1,221
0.06% 98
2023
Q1
$127K Buy
1,221
+8
+0.7% +$887 0.07% 97
2022
Q4
$140K Hold
1,213
0.08% 97
2022
Q3
$131K Buy
1,213
+79
+7% +$11.3K 0.09% 97
2022
Q2
$205K Buy
1,134
+1
+0.1% +$179 0.13% 91
2022
Q1
$193K Sell
1,133
-39
-3% -$7.35K 0.1% 96
2021
Q4
$245K Sell
1,172
-108
-8% -$22.3K 0.12% 94
2021
Q3
$247K Buy
1,280
+211
+20% +$51.9K 0.14% 91
2021
Q2
$303K Buy
+1,069
New +$290K 0.17% 85

Other funds holding MED